Brighton Jones LLC’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$474K Sell
2,491
-52
-2% -$8.94K 0.01% 816
2026
Q1
$429K Buy
+2,543
New +$435K 0.01% 760
2025
Q4
– Sell
-1,418
Closed -$205K – 451
2025
Q3
$205K Buy
+1,418
New +$194K ﹤0.01% 956
2025
Q2
– Sell
-1,769
Closed -$226K – 938
2025
Q1
$226K Buy
1,769
+252
+17% +$34.2K 0.01% 611
2024
Q4
$201K Buy
+1,517
New +$213K 0.01% 643
2024
Q3
– Sell
-1,681
Closed -$231K – 624
2024
Q2
$231K Buy
1,681
+1
+0.1% +$133 0.01% 535
2024
Q1
$230K Buy
+1,680
New +$229K 0.01% 534
2018
Q2
– Sell
-7,220
Closed -$771K – 307
2018
Q1
$771K Buy
7,220
+273
+4% +$30.3K 0.11% 109
2017
Q4
$742K Buy
6,947
+2
+0% +$214 0.09% 112
2017
Q3
$772K Buy
6,945
+4,503
+184% +$481K 0.1% 108
2017
Q2
$252K Buy
2,442
+36
+1% +$3.55K 0.04% 218
2017
Q1
$235K Buy
+2,406
New +$230K 0.06% 88
2016
Q4
– Sell
-2,403
Closed -$232K – 150
2016
Q3
$232K Sell
2,403
-384
-14% -$36.5K 0.04% 207
2016
Q2
$239K Buy
+2,787
New +$250K 0.04% 174
2014
Q1
– Sell
-3,000
Closed -$227K – 195
2013
Q4
$227K Hold
3,000
– – 0.05% 171
2013
Q3
$210K Buy
+3,000
New +$197K 0.06% 155

Other funds holding IBB

Brighton Jones LLC's IBB Position: Q2 2026 in Review

Brighton Jones LLC reduced its iShares Biotechnology ETF (IBB) stake by 2% in Q2 2026, selling an estimated $8.94K and leaving 2,491 shares worth $474K. The position accounts for 0.01% of the portfolio, ranked #816.

Brighton Jones LLC first reported a position in IBB in Q3 2013 and has held it in 16 quarters since. The position peaked at $772K in Q3 2017. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Brighton Jones LLC held 2,491 shares of iShares Biotechnology ETF worth $474K as of Q2 2026.
  • Brighton Jones LLC sold 52 iShares Biotechnology ETF shares in Q2 2026, an estimated $8.94K.
  • iShares Biotechnology ETF made up 0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #816 holding.
  • Brighton Jones LLC first reported a position in iShares Biotechnology ETF in Q3 2013 and has held it in 16 quarters since.
  • Brighton Jones LLC's iShares Biotechnology ETF position peaked at $772K in Q3 2017.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.